Fingerprint
Dive into the research topics of 'Nivolumab for metastatic renal cell carcinoma: Results of a randomized phase II trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Nivolumab for metastatic renal cell carcinoma: Results of a randomized phase II trial
Robert J. Motzer, Brian I. Rini, David F. McDermott, Bruce G. Redman, Timothy M. Kuzel, Michael R. Harrison, Ulka N. Vaishampayan, Harry A. Drabkin, Saby George, Theodore F. Logan, Kim A. Margolin, Elizabeth R. Plimack, Alexandre M. Lambert, Ian M. Waxman, Hans J. Hammers
Research output: Contribution to journal › Article › peer-review
898
Scopus
citations